Developmental Pharmacology and Therapeutics
Sex-Related Hyperthermic Response to Chlorpromazine in the Offspring of Rats Treated with ImipramineFujii T. · Ohtaki Y.Department of Pharmacology, Teikyo University School of Medicine, Itabashi, Tokyo, Japan
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Subscribe
For eJournal Archive and eJournal Backfiles information please contact Karger service
Article / Publication Details
Published online: August 11, 2017
Issue release date: 1985
Number of Print Pages: 10
Number of Figures: 0
Number of Tables: 0
ISSN: 0379-8305 (Print)
eISSN: 2504-2505 (Online)
For additional information: https://www.karger.com/DPD
Abstract
The body temperature in male rats bom to mothers treated with saline or imipramine (5 mg/kg, IMI-F(1)) from day 1 to day 21 of gestation showed a significant decline between 8 and 13 weeks of age. The magnitude of the decline was greater in the IMI-Fi rats than in saline-F, rats. In contrast, the body temperature in the IMI-F, female rats showed a significant rise between 8 and 13 weeks of age. Adult IMI-F(1) male rats showed a significant hyperthermia for 1-2 h after an injection of chlorpromazine while the littermate female rats and the control male and female rats showed a marked hypothermia. The results suggest that prenatal exposure to imipramine induces sex-related alterations in the thermoregulatory centers.
Related Articles:
Article / Publication Details
Published online: August 11, 2017
Issue release date: 1985
Number of Print Pages: 10
Number of Figures: 0
Number of Tables: 0
ISSN: 0379-8305 (Print)
eISSN: 2504-2505 (Online)
For additional information: https://www.karger.com/DPD
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission